▲ +61.96% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for Tilray in the last 3 months. The average price target is $10.90, with a high forecast of $20.00 and a low forecast of $4.00. The average price target represents a 61.96% upside from the last price of $6.73.
The current consensus among 14 investment analysts is to hold stock in Tilray.
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.